ClearPoint Neuro, Inc. — Director's Dealing 2025

Oct 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2025-10-10

Reporting Person: BURNETT JOSEPH (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-10	Common Stock	S	17583	$26.51	Disposed	225939	Indirect
2025-10-10	Common Stock	S	6599	$27.64	Disposed	219340	Indirect
2025-10-10	Common Stock	S	1981	$28.64	Disposed	217359	Indirect
2025-10-10	Common Stock	S	300	$29.21	Disposed	217059	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11311	Direct

Footnotes

F1: The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1.

F2: Represents a weighted average sales price per share. The shares were sold at prices ranging from $26.07 to $27.06. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.

F4: Represents a weighted average sales price per share. The shares were sold at prices ranging from $27.08 to $28.07. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F5: Represents a weighted average sales price per share. The shares were sold at prices ranging from $28.08 to $29.05. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.